Neuroendocrine Tumor Articles & Analysis
6 articles found
DLL3 plays a critical role in neurogenesis and is also implicated in various cancers, particularly in the development of neuroendocrine tumors. The ability to study DLL3 in a stable cell line allows researchers to elucidate its functions and interactions within the signaling pathways more comprehensively. ...
The core programs include: Octreotide for acromegaly or neuroendocrine tumors in the GI tract. Acromegaly is a hormonal disorder that develops when the pituitary gland produces too much growth hormone during adulthood. ...
They include: Octreotide for acromegaly or neuroendocrine tumors in the GI tract (NETs) TNF-alpha inhibitors for psoriatic arthritis Parathyroid hormone (PTH) for osteoporosis Human growth hormone (HGH) for HGH deficiency Parathyroid hormone for hypothyroidism The product furthest along in the research cycle is the pill developed to administer ...
Rani Therapeutics offers a breakthrough capsule, the RaniPill which could change the way patients with chronic conditions take medication by eliminating the need for painful injections. Rani Therapeutics is a clinical-stage biotherapeutics company offering an alternative to painful injections for patients with chronic conditions such as neuroendocrine tumours(NETS). The company based in ...
RT-101 is being evaluated for acromegaly, and Rani expects to run trials for neuroendocrine tumor of the gastrointestinal tract as well as carcinoid syndrome, the CEO said. ...
The use of labelled molecules with high specificity for an organ or receptor in scintigraphy generates good local images and minimises the exposure of other organs. Octreotide was the first somatostatin synthetic analogue introduced in clinical use in the localisation of tumours with superexpression of somatostatin receptor (sstr). This work studied the labelling of HYNIC-Tyr3-octreotide with ...